Corporate Responsibility Report

Overview

The report describes Neurocrine's purpose of relieving suffering through neuroscience medicines and reports approximately $2.3B in 2024 revenue and approximately 1,800 employees. It identifies the Board and its Nominating / Corporate Governance Committee as responsible for corporate responsibility oversight. Environmental highlights include the move to a new San Diego campus and recycling more than 99% of hazardous waste in 2024.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: Ends 31 December 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services